Barbara Peter

2.1k total citations
48 papers, 1.1k citations indexed

About

Barbara Peter is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Barbara Peter has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 24 papers in Molecular Biology and 11 papers in Hematology. Recurrent topics in Barbara Peter's work include Mast cells and histamine (25 papers), Polyamine Metabolism and Applications (11 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Barbara Peter is often cited by papers focused on Mast cells and histamine (25 papers), Polyamine Metabolism and Applications (11 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Barbara Peter collaborates with scholars based in Austria, Germany and United States. Barbara Peter's co-authors include Peter Valent, Karoline V. Gleixner, Emir Hadzijusufovic, Winfried F. Pickl, Rolf Schulte‐Hermann, Sabine Cerny‐Reiterer, Walter Rossmanith, Matthias Mayerhofer, Michael Willmann and Harald Herrmann and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Barbara Peter

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Peter Austria 21 417 392 186 145 141 48 1.1k
Elias Gounaris United States 18 637 1.5× 719 1.8× 70 0.4× 70 0.5× 60 0.4× 27 1.5k
Taylor B. Guo China 18 460 1.1× 663 1.7× 176 0.9× 44 0.3× 65 0.5× 35 1.5k
Theresa H. Page United Kingdom 18 449 1.1× 847 2.2× 98 0.5× 32 0.2× 96 0.7× 26 1.4k
Toru Miura Japan 18 342 0.8× 1.1k 2.8× 110 0.6× 38 0.3× 157 1.1× 31 1.6k
Stuart A. Berger Canada 23 632 1.5× 340 0.9× 74 0.4× 217 1.5× 97 0.7× 42 1.1k
Antonella Rigo Italy 21 550 1.3× 429 1.1× 58 0.3× 47 0.3× 285 2.0× 60 1.4k
Brian Bolognese United States 18 522 1.3× 380 1.0× 89 0.5× 44 0.3× 44 0.3× 34 1.2k
Guanhua Song China 19 829 2.0× 516 1.3× 100 0.5× 93 0.6× 27 0.2× 43 1.4k
Seiichiro Tarui Japan 17 523 1.3× 375 1.0× 96 0.5× 59 0.4× 108 0.8× 40 1.3k
Cong Peng China 20 655 1.6× 157 0.4× 152 0.8× 51 0.4× 288 2.0× 51 1.3k

Countries citing papers authored by Barbara Peter

Since Specialization
Citations

This map shows the geographic impact of Barbara Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Peter more than expected).

Fields of papers citing papers by Barbara Peter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Peter. The network helps show where Barbara Peter may publish in the future.

Co-authorship network of co-authors of Barbara Peter

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Peter. A scholar is included among the top collaborators of Barbara Peter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Peter. Barbara Peter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sadovnik, Irina, Barbara Peter, Gabriele Stefanzl, et al.. (2024). Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils. Cells. 13(2). 173–173. 5 indexed citations
2.
Valent, Peter, Irina Sadovnik, Barbara Peter, et al.. (2023). Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives. Expert Review of Hematology. 16(9). 659–670.
3.
Bandlitz, Stefan, et al.. (2020). Agreement and repeatability of four different devices to measure non-invasive tear breakup time (NIBUT). Contact Lens and Anterior Eye. 43(5). 507–511. 26 indexed citations
4.
Stefanzl, Gabriele, Barbara Peter, Karin Bauer, et al.. (2019). Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells. Veterinary and Comparative Oncology. 17(4). 553–561. 14 indexed citations
5.
Willmann, Michael, Emir Hadzijusufovic, Olivier Hermine, et al.. (2018). Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms. Veterinary and Comparative Oncology. 17(1). 1–10. 17 indexed citations
6.
Arock, Michel, Gregor Hoermann, Cem Akin, et al.. (2018). Preclinical human models and emerging therapeutics for advanced systemic mastocytosis. Haematologica. 103(11). 1760–1771. 13 indexed citations
7.
Valent, Peter, Cem Akin, Karin Hartmann, et al.. (2017). Midostaurin: a magic bullet that blocks mast cell expansion and activation. Annals of Oncology. 28(10). 2367–2376. 44 indexed citations
8.
Valent, Peter, Sabine Cerny‐Reiterer, Barbara Peter, et al.. (2014). Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage. Annals of Hematology. 94(2). 223–231. 12 indexed citations
9.
Gleixner, Karoline V., Barbara Peter, K. Blatt, et al.. (2013). Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V. Haematologica. 98(9). 1450–1457. 37 indexed citations
10.
Hadzijusufovic, Emir, Barbara Peter, Harald Herrmann, et al.. (2012). NI‐1: a novel canine mastocytoma model for studying drug resistance and IgER‐dependent mast cell activation. Allergy. 67(7). 858–868. 18 indexed citations
11.
Herrmann, Harald, Michael Kneidinger, Sabine Cerny‐Reiterer, et al.. (2012). The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on D34+/CD38+ and CD34+/CD38- AML Progenitor Cells. Current Cancer Drug Targets. 12(1). 51–63. 26 indexed citations
12.
Peter, Barbara, Karoline V. Gleixner, Sabine Cerny‐Reiterer, et al.. (2011). Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536. Haematologica. 96(5). 672–680. 12 indexed citations
13.
Gleixner, Karoline V., Barbara Peter, Alexander Gruze, et al.. (2010). Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536. Cancer Research. 70(4). 1513–1523. 74 indexed citations
14.
Peter, Barbara, Emir Hadzijusufovic, Katharina Blatt, et al.. (2010). KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406). Experimental Hematology. 38(9). 782–791. 10 indexed citations
15.
Böhm, Alexandra, Karoline Sonneck, Karoline V. Gleixner, et al.. (2010). In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V. Experimental Hematology. 38(9). 744–755. 36 indexed citations
16.
Hadzijusufovic, Emir, Barbara Peter, Christian Baumgärtner, et al.. (2009). Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation. Veterinary Immunology and Immunopathology. 132(2-4). 243–250. 15 indexed citations
17.
Baumgärtner, Christian, Karoline V. Gleixner, Barbara Peter, et al.. (2008). Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRα. Experimental Hematology. 36(10). 1244–1253. 22 indexed citations
18.
Vejda, Susanne, Mark Cranfield, Barbara Peter, et al.. (2002). Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers. Journal of Molecular Endocrinology. 28(2). 137–148. 55 indexed citations
19.
Vejda, Susanne, Carsten Posovszky, Sieglinde Zelzer, et al.. (2002). Plasma from Cancer Patients Featuring a Characteristic Protein Composition Mediates Protection against Apoptosis. Molecular & Cellular Proteomics. 1(5). 387–393. 33 indexed citations
20.
Huber, Wolfgang W., Gerlinde Scharf, Walter Rossmanith, et al.. (2001). The coffee components kahweol and cafestol induce γ-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Archives of Toxicology. 75(11-12). 685–694. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elias Gounaris Breakdown of academic impact, for papers by Taylor B. Guo Breakdown of academic impact, for papers by Theresa H. Page Breakdown of academic impact, for papers by Toru Miura Breakdown of academic impact, for papers by Stuart A. Berger Breakdown of academic impact, for papers by Antonella Rigo Breakdown of academic impact, for papers by Brian Bolognese Breakdown of academic impact, for papers by Guanhua Song Breakdown of academic impact, for papers by Seiichiro Tarui Breakdown of academic impact, for papers by Cong Peng
Rankless by CCL
2026